Sort   by:  
 Page size 
UnknownSex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Not available
S-EPMC11150359 | biostudies-literature
UnknownEnzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.
Not available
S-EPMC13472872 | biostudies-literature
UnknownReal-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study.
Not available
S-EPMC12618741 | biostudies-literature
UnknownPembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1).
Not available
S-EPMC12116974 | biostudies-literature
UnknownEnfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.
Not available
S-EPMC11557677 | biostudies-literature
Sort   by:  
 Page size